SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?


To: fred hayes who wrote (189)1/13/2005 12:29:49 AM
From: tuckRead Replies (1) | Respond to of 802
 
Zeta and I both know INGN owns gene therapy applications of MDA-7 three ways from Sunday, guys. I'm sorry I wasn't clear that I wasn't talking about that. I was talking about the use of the PEG-3 promoter, which appears to be a different matter, and not limited to MDA-7.

I wanted to know if INGN has the rights to this use of PEG-3.

Cheers, Tuck